Skip to content

Price / book at other companies

Eli Lilly logo
Eli LillyLLY
26.3×-20.7×
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
+3.9×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
125.1×+108×
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
3.6×-5.6×
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
3.5×+0.3×
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
4.4×+2.2×

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.56B-45.9%
Enterprise value$1.36B-50.0%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Calculated from MoonLake Immunotherapeutics’s reported figures.

Based on the most recent quarter.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MoonLake Immunotherapeutics's price / book?
MoonLake Immunotherapeutics (MLTX) reported price / book of 5.3× in Q1 2026.
How has MoonLake Immunotherapeutics's price / book changed year-over-year?
MoonLake Immunotherapeutics's price / book decreased by 13.2% year-over-year, from 6.1× to 5.3×.
What is the long-term trend for MoonLake Immunotherapeutics's price / book?
Over 3 years (2022 to 2025), MoonLake Immunotherapeutics's price / book has grown at a -28.4% compound annual growth rate (CAGR), from 8.3× to 3.1×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.